298380.KQ
Price:
$75200
Market Cap:
$4.21T
ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea. The firm is dedicated to advancing therapeutic medications, primarily concentrating its efforts on treatments for immuno-oncology and neurodegenerative conditions. Its current lineup of investigational drugs features ABL001, various cancer immunotherapies, ADCs, and ABL301.
Industry
Biotechnology
IPO Date
2018-12-19
Stock Exchange
KOE
Ticker
298380.KQ
According to ABL Bio Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -42.68. This represents a change of -58.10% compared to the average of -101.86 of the last 4 quarters.
The mean historical PE Ratio of ABL Bio Inc. over the last ten years is -55.29. The current -42.68 PE Ratio has changed 7.62% with respect to the historical average. Over the past ten years (40 quarters), 298380.KQ's PE Ratio was at its highest in in the June 2022 quarter at 140.59. The PE Ratio was at its lowest in in the March 2026 quarter at -158.99.
Average
-55.29
Median
-23.19
Minimum
-435.65
Maximum
332.79
Discovering the peaks and valleys of ABL Bio Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.00%
Maximum Annual PE Ratio = 332.79
Minimum Annual Increase = -1496.45%
Minimum Annual PE Ratio = -435.65
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -284.34 | 1.00% |
| 2024 | -25.84 | -94.07% |
| 2023 | -435.65 | -230.91% |
| 2022 | 332.79 | -1496.45% |
| 2021 | -23.83 | 55.93% |
| 2020 | -15.28 | -32.22% |
| 2019 | -22.55 | 219.05% |
| 2018 | -7.07 | -35.80% |
| 2017 | -11.01 | -81.69% |
The current PE Ratio of ABL Bio Inc. (298380.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-248.61
5-year avg
-87.37
10-year avg
-55.29
ABL Bio Inc.’s PE Ratio is less than Sam Chun Dang Pharm. Co., Ltd (221.20), less than Hanmi Pharm. Co., Ltd. (22.51), less than HLB Co., Ltd. (-23.93), less than Kolon TissueGene, Inc. (-9.47), less than SK bioscience Co.,Ltd. (-34.23), less than CLASSYS Inc. (15.26), less than LigaChem Biosciences Inc. (-18.68), less than ST Pharm Co.,Ltd. (26.97), less than PharmaResearch Co., Ltd. (22.41), less than Voronoi, Inc. (-37.33),
| Company | PE Ratio | Market cap |
|---|---|---|
| 221.20 | $3.95T | |
| 22.51 | $5.27T | |
| -23.93 | $5.14T | |
| -9.47 | $1.76T | |
| -34.23 | $2.86T | |
| 15.26 | $2.10T | |
| -18.68 | $3.64T | |
| 26.97 | $2.08T | |
| 22.41 | $4.16T | |
| -37.33 | $2.79T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABL Bio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ABL Bio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ABL Bio Inc.'s PE Ratio?
How is the PE Ratio calculated for ABL Bio Inc. (298380.KQ)?
What is the highest PE Ratio for ABL Bio Inc. (298380.KQ)?
What is the 3-year average PE Ratio for ABL Bio Inc. (298380.KQ)?
What is the 5-year average PE Ratio for ABL Bio Inc. (298380.KQ)?
How does the current PE Ratio for ABL Bio Inc. (298380.KQ) compare to its historical average?